Latest Antiandrogens Stories
Ariad Pharmaceuticals, a developer of medicines to treat cancer, has announced the initiation of a Phase II clinical trial by Merck & Co to evaluate the safety and efficacy of oral deforolimus, Ariad's investigational mTOR inhibitor, in patients with advanced prostate cancer.
Cougar Biotechnology, Inc. (NASDAQ:CGRB) today announced that results from an ongoing Phase II clinical trial of Cougar's investigational drug CB7630 (abiraterone acetate) were presented today at the Prostate Cancer Foundation Scientific Retreat.
By Marie Price A new law requiring women to undergo an ultrasound before getting an abortion has been challenged in a lawsuit filed in Oklahoma County District Court by the Center for Reproductive Rights on behalf of Nova Health Systems, which does business as Reproductive Services in Tulsa.
US-based healthcare company AstraZeneca has announced that the FDA has granted an additional six-month period of exclusivity to market Casodex for its licensed advanced prostate cancer indication until April 1, 2009.
Men with locally advanced prostate cancer will survive substantially longer when radiation is added to their treatment plan, Swedish researchers said. Lead author Dr.
WILMINGTON, Del., Sept.
Some drugs given to men to help treat prostate cancer may actually spur some cancer cells to grow, U.S. researchers said.
SCIENTISTS are hailing a new drug to treat aggressive prostate cancer as potentially the most significant advance in the field for 70 years. Abiraterone could treat up to 80% of patients with a deadly form of the disease resistant to currently available chemotherapy, they said.
Barrier Therapeutics, Inc. (NASDAQ: BTRX) announced today the introduction of Xolegel CorePak(TM) for the treatment of seborrheic dermatitis. Now, patients with this chronic skin condition need only one prescription to get quick itch relief and to safely manage the overall condition long term.
By Phil Skelton Health reporter Prostate cancer patients in Gloucestershire have welcomed news of a new drug to treat an aggressive form of the disease. Abiraterone has been developed to fight prostate cancer, which kills 9,000 men in England and Wales every year, according to the NHS.
- A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.